Exploring the Muco-Microbiotic Interface as a Hub for Microbial Metabolites and Immune Regulation in Gastroenteric Health and Disease
Cells · 2025
DOI: 10.3390/cells15010045 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2025. Verfasst von Adelaide Carista und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedicine, Neurosciences and Advanced Diagnostics (BiND), University of Palermo, 90127 Palermo, Italy. Hauptthemen laut MEDLINE: Mucus, Gastrointestinal Microbiome, Gastrointestinal Diseases, Gastrointestinal Tract. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The mucus layer covering the gastrointestinal tract forms a specialised interface where mucins, microbes, and extracellular vesicles create a dynamic, self-regulating ecosystem. Here, we introduce the concept of the muco-microbiotic layer as an integrated eco-physiological system that maintains mucosal homeostasis through coordinated structural, metabolic, and immune functions. The MuMi layer varies regionally in its biochemical composition, microbial inhabitants, and environmental parameters—from the acidic stomach to the anaerobic colon—thereby generating distinct niches for microbial colonisation and metabolite production. We summarise current evidence on how mucin glycans, mucus-associated microbiota, and vesicle-mediated signalling sustain barrier integrity, nutrient flux, and immune tolerance. Perturbations in any of these components lead to barrier failure, microbial encroachment, and inflammation, contributing to a broad spectrum of disorders, including gastritis, inflammatory bowel disease, colorectal cancer, and metabolic syndrome. Methodological advances such as organoid and mucus-on-chip models, spatial multi-omics, and vesiculomics are now enabling site-specific analyses of this complex system. Conceptually, defining the mucus, microbiota, and vesicular compartments as a single MuMi layer provides a new framework for understanding mucosal physiology and pathophysiology, emphasising the interdependence between structure and function. Integrating this perspective into experimental and clinical research may open new avenues for diagnostics and therapies targeting mucosal health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedicine, Neurosciences and Advanced Diagnostics (BiND), University of Palermo, 90127 Palermo, Italy.
- Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Viale delle Scienze Ed. 16, 90128 Palermo, Italy.
- Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialities "G. D'Alessandro", University of Palermo, 90127 Palermo, Italy.
- Department of Medicine and Surgery, Kore University of Enna, 94100 Enna, Italy.
ORCID-Profile: Adelaide Carista, Enrico Tornatore, Giovanni Tomasello, Domiziana Picone, Stefano Burgio, Francesco Cappello
Zitieren
APA
Carista, A., Gratie, M. I., Tornatore, E., Accomando, S., Tomasello, G., Picone, D., Burgio, S., & Cappello, F. (2025). Exploring the Muco-Microbiotic Interface as a Hub for Microbial Metabolites and Immune Regulation in Gastroenteric Health and Disease. Cells. https://doi.org/10.3390/cells15010045
Vancouver
Carista A, Gratie MI, Tornatore E, Accomando S, Tomasello G, Picone D, et al. Exploring the Muco-Microbiotic Interface as a Hub for Microbial Metabolites and Immune Regulation in Gastroenteric Health and Disease. Cells. 2025. doi:10.3390/cells15010045
BibTeX
@article{Carista2025,
author = {Carista, Adelaide and Gratie, Melania Ionelia and Tornatore, Enrico and Accomando, Salvatore and Tomasello, Giovanni and Picone, Domiziana and Burgio, Stefano and Cappello, Francesco},
title = {Exploring the Muco-Microbiotic Interface as a Hub for Microbial Metabolites and Immune Regulation in Gastroenteric Health and Disease},
journal = {Cells},
year = {2025},
doi = {10.3390/cells15010045}
}
EUVIMED